NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	LIC MF Healthcare Fund - Direct (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Fund Type	Equity	Equity
Risk	Very High	Very High
Min SIP Amount	₹100	₹100
Min Lumpsum	₹5,000	₹500
Expense Ratio	1.38%	1.07%
NAV	₹38.51 (11 Nov 2026)	₹18.37 (11 Nov 2026)
Fund Size	₹96.54 Cr	₹964.26 Cr
Fund Started	28 Feb 2019	06 Feb 2024
Lock-in Period	No lock-in	No lock-in
Exit Load	Nil - If units of the Scheme are redeemed or switched out up to 12% of the units within 90 days from the date of allotment. 1.00% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment.	NIL.

Returns	LIC MF Healthcare Fund - Direct (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
1M	7.34%	8.70%
3M	2.33%	5.33%
6M	12.99%	18.50%
1Y	18.04%	26.29%
3Y	21.87%	—
5Y	14.26%	—
Since Inception	19.12%	24.72%

Trailing risk-adjusted performance measures

Risk Ratio	LIC MF Healthcare Fund - Direct (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Alpha	15.58	18.26
Beta	0.69	0.66
Sharpe	0.98	0.98
Standard Deviation	4.65	4.63

Holding Analysis	LIC MF Healthcare Fund - Direct (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Top 5 Holdings	33.67%	31.19%
Top 10 Holdings	55.46%	47.59%
Portfolio Turnover	0.42	1.79
Equity	96.20%	90.72%
Debt	3.37%	8.70%
Cash	—	—

Name	Assets
Sun Pharmaceutical ...Equity	8.65%
Divis Laboratories LtdEquity	7.09%
Apollo Hospitals En...Equity	6.13%
Torrent Pharmaceuti...Equity	5.97%
Neuland Laboratorie...Equity	5.83%
Aurobindo Pharma LtdEquity	5.41%
Aster DM Quality Ca...Equity	4.64%
Nephrocare Health S...Equity	4.14%
Fortis Healthcare LtdEquity	3.87%
Metropolis Healthca...Equity	3.73%

Fund Manager	LIC MF Healthcare Fund - Direct (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
Name	,	, , , , ,

About	LIC MF Healthcare Fund - Direct (G)	WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
AMC	LIC Mutual Fund	WhiteOak Capital Mutual Fund
Scheme Category	Sectoral Fund	Sectoral Fund
Benchmark	BSE Healthcare TRI	BSE Healthcare TRI
Launch Date	08 Feb 2019	16 Jan 2024

Divis Laboratories LtdEquity	8.36%
Sun Pharmaceutical ...Equity	7.11%
Torrent Pharmaceuti...Equity	6.26%
C C IReverse Repo	5.55%
Laurus Labs LtdEquity	3.91%
Apollo Hospitals En...Equity	3.75%
Cipla LtdEquity	3.68%
Sai Life Sciences LtdEquity	3.28%
Ipca Laboratories LtdEquity	2.88%
Zydus Lifesciences LtdEquity	2.81%